Phenazopyridine-induced sulfhemoglobinemia

Annals of Pharmacotherapy

Volumn 39, Issue 6, 2005, Pages 1128-1130

  Gopalachar, Anuradha S ^a,b   Bowie, Venita L ^a,b   Bharadwaj, Parag ^c  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER   (United States)

^c San Diego Hospice and Palliative Care   (United States)

Author keywords

Phenazopyridine; Sulfhemoglobinemia; Urinary tract infection

Indexed keywords

HEMOGLOBIN; METHEMOGLOBIN; METHYLENE BLUE; PHENAZOPYRIDINE; SULFHEMOGLOBIN;

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; CYANOSIS; DYSURIA; EMERGENCY WARD; ERYTHROCYTE TRANSFUSION; FATIGUE; FEMALE; HEMATOLOGIC DISEASE; HUMAN; LABORATORY TEST; MEDICAL EXAMINATION; PRIORITY JOURNAL; SKIN DISCOLORATION; SPECTROPHOTOMETRY; URINARY TRACT INFECTION;

ADMINISTRATION, ORAL; FEMALE; HUMANS; MIDDLE AGED; PHENAZOPYRIDINE; SULFHEMOGLOBINEMIA; URINARY TRACT INFECTIONS;

EID: 18844450756     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1E557     Document Type: Article

References (12)

1. Lukens JN. Methemoglobinemia and other disorders accompanied by cyanosis. In: Lee GR, Foerster J, Lukens JN, Paraskevas F, Greer JP, Rodgers GM, eds. Wintrobe's clinical hematology. 10th ed. Philadelphia: Lippincott Williams and Wilkins, 1999:1046-55.
2. Steven CC, Michael WC. Hematologic consequences of poisoning. In: Haddad LM, Shannon MW, Winchester JF, eds. Clinical management of poisoning and drug overdose. 3rd ed. Philadelphia: WB Saunders Co., 1998:223-35.
3. Finch CA. Methemoglobin and sulfhemoglobin. N Engl J Med 1948; 239:470-8.
4. Burlet RA, Trudeau TW. Phenazopyridine. In: Drugdex System. Englewood, CO: Micromedex, Inc. (edition expired 6/2004).
5. Demedts P, Wauters A, Watelle M, Neels H. Pitfalls in discriminating sulfhemoglobinemia from methemoglobinemia (letter). Clin Chem 1997; 43(6 pt 1):1098-9.
6. Siggaard-Andersen O, Norgaard-Pedersen B, Rem J. Hemoglobin pigments. Spectrophotometric determination of oxy-carboxy-, met-, and sulfhemoglobin in capillary blood. Clin Chim Acta 1972;42:85-100.
7. Park CM, Nagel RL. Sulfhemoglobinemia: clinical and molecular aspects. N Engl J Med 1984;310:1579-84.
8. Wright RO, Lewander WJ, Woolf AD. Methemoglobinemia: etiology, pharmacology and clinical management. Ann Emerg Med 1999;34:646-56.
9. Rausch-Madison S, Mohsenifar Z. Methodologic problems encountered with cooximetry in methemoglobinemia. Am J Med Sci 1997;314:203-6.
10. Halvorsen SM, Dull WL. Phenazopyridine-induced sulfhemoglobinemia: inadvertent rechallenge. Am J Med 1991;91:315-7.
11. Barrueto F Jr, Ryon D, Howland MA, Hoffman RS, Nelson LS. Phenazopyridine-induced sulfhemoglobinemia (abstract). J Toxicol Clin Toxicol 2003;41:470.
12. Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981;30:239-45.